Literature DB >> 20390467

Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.

Petros D Grivas1.   

Abstract

We report a 62-year-old man who developed biopsy-proven post-transplantation lymphoproliferative disorder (PTLD) 20 years after receiving a heart transplant while being treated with immunosuppressive agents. The patient presented with large retroperitoneal and intestinal wall masses that caused partial gastrointestinal stenosis. Monoclonal antibody against CD20 in conjunction with chemotherapy and tapering of the immunosuppressive regimen was instituted, resulting in objective response of the disease bulk. To the best of our knowledge, this is the second reported case of PTLD 20 years after heart transplantation.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20390467     DOI： 10.1007/s12032-010-9523-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  35 in total

1.  Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.

Authors:  Francis K Buadi; Meyer R Heyman; Christopher D Gocke; Aaron P Rapoport; Roger Hakimian; Stephen T Bartlett; Clarence Sarkodee-Adoo
Journal:  Am J Hematol       Date:  2007-03       Impact factor: 10.047

Review 2.  Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Authors:  C V Paya; J J Fung; M A Nalesnik; E Kieff; M Green; G Gores; T M Habermann; P H Wiesner; J L Swinnen; E S Woodle; J S Bromberg
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

Review 3.  The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.

Authors:  M Green; J Reyes; S Webber; D Rowe
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

4.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Authors:  F Wang; C Gregory; C Sample; M Rowe; D Liebowitz; R Murray; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3.

Authors:  C A Keever-Taylor; A Craig; M Molter; P Fu; A Loebel; J Skonecki; H Zeng; B Giesen
Journal:  Cytotherapy       Date:  2001       Impact factor: 5.414

6.  Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Authors:  Sanjeev Wasson; Mohammad N Zafar; John Best; Hanumanth K Reddy
Journal:  J Cardiovasc Pharmacol Ther       Date:  2006-03       Impact factor: 2.457

Review 7.  Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors:  J K Preiksaitis; S Keay
Journal:  Clin Infect Dis       Date:  2001-07-01       Impact factor: 9.079

8.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

9.  Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.

Authors:  Pau Montesinos; Ignacio Lorenzo; Guillermo Martín; Jaime Sanz; Maria Luz Pérez-Sirvent; David Martínez; Guillermo Ortí; Lorenzo Algarra; Jesus Martínez; Federico Moscardó; Javier de la Rubia; Isidro Jarque; Guillermo Sanz; Miguel A Sanz
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

10.  Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.

Authors:  Sylvain Choquet; Stephan Oertel; Veronique LeBlond; Hanno Riess; Nathalie Varoqueaux; Bernd Dörken; Ralf Trappe
Journal:  Ann Hematol       Date:  2007-05-24       Impact factor: 3.673
View more
  2 in total

1.  Posttransplant Lymphoproliferative Disorder of the Small Bowel as an Unexpected Cause of Iron Deficiency Anemia Decades after Heart Transplantation.

Authors:  Amanda Siegel; Justin Boike; Itishree Trivedi; Rena Yadlapati
Journal:  ACG Case Rep J       Date:  2017-07-05

2.  A case report: pause and consider the late complications of heart transplantation.

Authors:  Tejas Sinha; Amanda Lyon; Rami Kahwash
Journal:  Eur Heart J Case Rep       Date:  2019-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.